Sychedelic develops a closed-loop neuromodulation wearable in a headphone form factor that integrates tDCS, binaural beats, HRV biofeedback and adaptive AI to monitor and respond to users' mental states in real time. The device is positioned to support stress reduction, focus enhancement, sleep support and overall mental wellness. The company has run a six-month pilot with more than 100 early adopters to refine its hardware, stimulation systems and adaptive algorithms. Sychedelic has secured CDSCO approval in India granting it medical device status and has filed global patent applications that are patent-pending. It operates across India and the US and plans an international Kickstarter launch in May 2026. The recent $3.5 million seed raise will fund marketing, manufacturing scale-up and expanded research.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

May 2026